Start Date
Immediate
Expiry Date
11 Sep, 25
Salary
173888.0
Posted On
12 Jun, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Drug Development, Biologics, Cancer Biology, Bioengineering, Cell Biology, Communication Skills, Oncology, Regulatory Submissions, Immunology, Adcs, Antibodies
Industry
Pharmaceuticals
COMPANY OVERVIEW
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
POSITION OVERVIEW
We are looking for a talented and passionate cancer biologist with experience developing and championing novel therapeutic concepts in a fast-paced and scientifically rigorous environment. The position will challenge you to leverage your deep understanding of cancer biology and pharmacology to engineer the next generation of targeted cancer therapeutics. In partnership with cross-functional teams across the company, you will lead the discovery, optimization, and nomination of new drug candidates for clinical development.
KNOWLEDGE AND SKILLS
Qualifications
Contribute to the preparation and review of regulatory documents, including IND submissions, ensuring compliance with regulatory requirements.
Qualifications
Ph.D. in Cell Biology, Cancer Biology, Bioengineering, Immunology, or related field.